Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024 [Financial Post (Toronto, Ontario, Canada)]
Aptose Biosciences, Inc. - Common Shares (APTO)
Last aptose biosciences, inc. - common shares earnings: 3/10 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
aptose.com/investors
Company Research
Source: Financial Post
SAN DIEGO and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended March 31, 2024, on Tuesday, May 14, 2024, after the close of the market, and provide a corporate update. In addition, Rafael Bejar, MD, PhD, the Company's Chief Medical Officer and resident Key Opinion Leader, will review a selection of slides and discuss the clinical strategy for advancing the Company's lead asset tuspetinib (TUS) in a TUS+VEN+HMA triplet drug combination for the frontline treatment of newly diagnosed AML patients. Article content Conference Call & Webcast: Article content Date: Tuesday, May 14, 2024 Time: 5:00 PM ET Webcast Only (will include slides): Q&A Participant Registration Link*: https://register.vevent.com/register/BIebf7d306b67a4388b6a8d9cc63464
Show less
Read more
Impact Snapshot
Event Time:
APTO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APTO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APTO alerts
High impacting Aptose Biosciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
APTO
News
- Aptose Biosciences Inc. (NASDAQ: APTO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $15.00 to $6.00. They now have a "buy" rating on the stock.MarketBeat
- Aptose Reports Results for the First Quarter 2024 [Yahoo! Finance]Yahoo! Finance
- Aptose Reports Results for the First Quarter 2024 [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Aptose Reports Results for the First Quarter 2024GlobeNewswire
- Aptose Biosciences Inc. (NASDAQ: APTO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
APTO
Earnings
- 5/14/24 - Beat
APTO
Sec Filings
- 5/15/24 - Form DEF
- 5/14/24 - Form 10-Q
- 5/14/24 - Form 8-K
- APTO's page on the SEC website